Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,157) with videos related to
Page
of 116
Sort By:
Annals of Clinical and Translational Neurology
|
January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy
Ermelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Journal of Neurology
|
September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study
Ferdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
European Stroke Journal
|
February 17, 2025
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients
Aurora Semerano, Beatrice Dell'Acqua, Angela Genchi, et al.
Nature Reviews. Neurology
|
May 19, 2026
Rethinking prognosis in multiple sclerosis: a multiaxial perspective
Luca Prosperini, Carla Tortorella, Frederik Barkhof, et al.
Journal of Neuroimmunology
|
August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab
Alessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 14, 2016
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease
Lidia Sarro, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Journal of Neurology
|
August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Marta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
European Journal of Neurology
|
September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis
Irene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
The Lancet. Neurology
|
September 5, 2009
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Paul O'Connor, Massimo Filippi, Barry Arnason, et al.
Neurology
|
October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study
Massimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Page
of 116
Search research articles
Search
Showing results (1031-1040 of 1,157) with videos related to
Sort By:
Page
of 116
Annals of Clinical and Translational Neurology
|
January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy
Ermelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.
Journal of Neurology
|
September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study
Ferdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
European Stroke Journal
|
February 17, 2025
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients
Aurora Semerano, Beatrice Dell'Acqua, Angela Genchi, et al.
Nature Reviews. Neurology
|
May 19, 2026
Rethinking prognosis in multiple sclerosis: a multiaxial perspective
Luca Prosperini, Carla Tortorella, Frederik Barkhof, et al.
Journal of Neuroimmunology
|
August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab
Alessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 14, 2016
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease
Lidia Sarro, Nirubol Tosakulwong, Christopher G Schwarz, et al.
Journal of Neurology
|
August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Marta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
European Journal of Neurology
|
September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosis
Irene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
The Lancet. Neurology
|
September 5, 2009
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Paul O'Connor, Massimo Filippi, Barry Arnason, et al.
Neurology
|
October 30, 2021
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study
Massimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
Page
of 116